Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial

BACKGROUND: The efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndrome and prior myocardial infarction (MI) remain unstudied. We aimed to assess the treatment effect of ticagrelor versus prasugrel according to prior MI status in patients with ACS. METHODS AND RES...

Descripción completa

Detalles Bibliográficos
Autores principales: Lahu, Shqipdona, Scalamogna, Maria, Ndrepepa, Gjin, Menichelli, Maurizio, Valina, Christian, Hemetsberger, Rayyan, Witzenbichler, Bernhard, Bernlochner, Isabell, Joner, Michael, Xhepa, Erion, Hapfelmeier, Alexander, Kufner, Sebastian, Sager, Hendrik B., Mayer, Katharina, Kessler, Thorsten, Laugwitz, Karl‐Ludwig, Richardt, Gert, Schunkert, Heribert, Neumann, Franz‐Josef, Kastrati, Adnan, Cassese, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798807/
https://www.ncbi.nlm.nih.gov/pubmed/36515247
http://dx.doi.org/10.1161/JAHA.122.027257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798807/
https://www.ncbi.nlm.nih.gov/pubmed/36515247
http://dx.doi.org/10.1161/JAHA.122.027257

Ejemplares similares